Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.

By F. Zhu, Jun Zhang, Xue-feng Zhang, Cheng Zhou, Zhong-ze Wang, Shoujie Huang, Hua Wang, Changlin Yang, Hanmin Jiang, Jiaping Cai and 13 more. The Lancet, 2010

713 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/91e0082a8000920ae90fc3657828d439e0fd9358

Citations in the corpus

• Self-assembling protein nanoparticles in the design of vaccines (2015, neutral): “8% efficacy and is currently in phase IV clinical trials (Hecolin) [72,73].”